9-21971149-G-T

Variant names:

• chr9-21971149-G-T
• rs864622570
• NM_058195.4:c.253C>A
• CDKN2A p.Gln85Lys

GermlineCancer (beta)

Variant summary

Our verdict is Uncertain significance.

+2 Uncertain · Warm

-7

-6

-1

0

+5

+6

+9

+10

BenignB

Likely BenignLB

UncertainVUS

Likely PathogenicLP

PathogenicP

The variant received 2 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_Moderate

The NM_058195.4(CDKN2A):c.253C>A (p.Gln85Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene CDKN2A is a tumor suppressor gene (CancerMine: 433 TSG, 144 oncogene, 88 driver citations). The gene CDKN2A is a known oncogene (CancerMine: 433 TSG, 144 oncogene, 88 driver citations). The gene CDKN2A is a cancer driver gene (CancerMine: 433 TSG, 144 oncogene, 88 driver citations). The variant allele was found at a cumulative frequency of 0.000000693 (AC=1) in the gnomAD database across 1,441,980 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000117. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.Q85*: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 220535); p.Q85H: Uncertain_significance (ClinVar VariationId 1786361, 2 stars); p.Q85L: Uncertain_significance (ClinVar VariationId 485514, 1 star)

• Frequency:
  • Genomes: not found (cov: 32)
  • Exomes 𝑓: 6.9e-7 (0 hom.)
• Consequence: CDKN2A NM_058195.4 missense
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 0.958
• Publications: 1 publications found

Genes affected

CDKN2A (HGNC:1787): (cyclin dependent kinase inhibitor 2A) This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012]

CDKN2A Gene-Disease associations (from GenCC):

• melanoma, cutaneous malignant, susceptibility to, 2

  Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
• melanoma-pancreatic cancer syndrome

  Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, Ambry Genetics
• familial atypical multiple mole melanoma syndrome

  Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
• melanoma and neural system tumor syndrome

  Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

ENSG00000264545 (HGNC:):

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 2 points.

Apply	Criterion Code & Title / Strength	Strength	Rationale / Clinical Context
	O3Absent or very rare in population		Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = 0.000012, AC = 1 — absent/extremely rare (O3 moderate [+2])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_058195.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.	Gene / Transcript	Tags	HGVSc / HGVSp	Effect	Exon rank	Protein / UniProt
	CDKN2A NM_058195.4	MANE Plus Clinical	c.253C>A p.Gln85Lys	missense	Exon 2 of 3	Prot: NP_478102.2 UniProt:
	CDKN2A NM_000077.5	MANE Select	c.210C>A p.Pro70Pro	synonymous	Exon 2 of 3	Prot: NP_000068.1 UniProt:
	CDKN2A NM_001195132.2		c.210C>A p.Pro70Pro	synonymous	Exon 2 of 4	Prot: NP_001182061.1 UniProt:

CDKN2A NM_058195.4

MANE Plus Clinical

HGVSc / HGVSpc.253C>Ap.Gln85Lys

Exon rankExon 2 of 3

missense

Prot: NP_478102.2UniProt: Q8N726-1

CDKN2A NM_000077.5

MANE Select

HGVSc / HGVSpc.210C>Ap.Pro70Pro

Exon rankExon 2 of 3

synonymous

Prot: NP_000068.1UniProt: K7PML8P42771-1

CDKN2A NM_001195132.2

HGVSc / HGVSpc.210C>Ap.Pro70Pro

Exon rankExon 2 of 4

synonymous

Prot: NP_001182061.1UniProt: P42771-4

Ensembl Transcripts

Sel.	Gene / Transcript	Tags	HGVSc / HGVSp	Effect	Exon rank	Protein / UniProt
	CDKN2A ENST00000579755.2	TSL:1MANE Plus Clinical	c.253C>A p.Gln85Lys	missense	Exon 2 of 3	Prot: ENSP00000462950.1 UniProt:
	CDKN2A ENST00000304494.10	TSL:1MANE Select	c.210C>A p.Pro70Pro	synonymous	Exon 2 of 3	Prot: ENSP00000307101.5 UniProt:
	CDKN2A ENST00000498124.1	TSL:1	c.210C>A p.Pro70Pro	synonymous	Exon 2 of 4	Prot: ENSP00000418915.1 UniProt:

CDKN2A ENST00000579755.2

TSL:1MANE Plus Clinical

HGVSc / HGVSpc.253C>Ap.Gln85Lys

Exon rankExon 2 of 3

missense

Prot: ENSP00000462950.1UniProt: Q8N726-1

CDKN2A ENST00000304494.10

TSL:1MANE Select

HGVSc / HGVSpc.210C>Ap.Pro70Pro

Exon rankExon 2 of 3

synonymous

Prot: ENSP00000307101.5UniProt: P42771-1

CDKN2A ENST00000498124.1

TSL:1

HGVSc / HGVSpc.210C>Ap.Pro70Pro

Exon rankExon 2 of 4

synonymous

Prot: ENSP00000418915.1UniProt: P42771-4

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)

Rare (AF ≤ 0.0001 / Hom ≤ 1)

Source / population	AF	AC	Hom	AN	Coverage
Global population databases 3 sources Large-scale international reference populations
GnomAD3 genomes	AF:	AC:	Hom:	AN:	Cov:32
GnomAD4 exome	AF: 6.93e-7	AC:1	Hom:0	AN:1441980	Cov:31
GnomAD4 genome	AF:	AC:	Hom:	AN:	Cov:32

Showing 3 sources

ClinVar

Not reported in ClinVar

Computational Scores

Algorithm	Calibrated pred.	Score	Prediction
AlphaGenome AVI	Pathogenic	21
AlphaMissense	Benign	0.24
BayesDel_addAF	Uncertain	0.091	D
BayesDel_noAF	Benign	-0.11
CADD	Benign	13
DANN	Uncertain	0.99
DEOGEN2	Benign	0.034	T
Eigen	Benign	0.15
Eigen_PC	Benign	0.21
FATHMM_MKL	Uncertain	0.88	D
GPN-Star LLR	N/A	-4.0
GPN-Star score	N/A	4.0
LIST_S2	Benign	0.51	T
M_CAP	Uncertain	0.18	D
MetaRNN	Uncertain	0.57	D
MetaSVM	Uncertain	-0.23	T
Mutation Taster	N/A	42/58	disease causing
PhyloP100	Benign	0.96
PrimateAI	Uncertain	0.58	T
PromoterAI	N/A	-0.020	Neutral
PROVEAN	Benign	-2.1	N
REVEL	Uncertain	0.42
Sift	Uncertain	0.023	D
Sift4G	Uncertain	0.042	D

Showing 24 of 24 scores

Splicing Scores

Algorithm	Calibrated pred.	Score	Prediction
Pangolin (max)	Benign	0.0
SpliceAI score (max)	Benign	0.0	Details are displayed if max score is > 0.2

Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Other links and lift over

dbSNP: rs864622570;

hg19: chr9-21971148;

COSMIC: COSV114579218;

ACMG debug oncogenicity

ACGS debug oncogenicity

ACMG debug germline

Submit to ClinVar